AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical business, creating innovative medicines for millions of patients worldwide. The company focuses on the research, development, and commercialization of prescription medicines in areas such as Oncology, BioPharmaceuticals, and Rare Diseases. With a commitment to improving patient care, AstraZeneca invests heavily in discovering drugs that provide significant benefits in challenging health conditions, ensuring that innovations lead to real-life applications that enhance patient outcomes.

Founded through a merger in 1999, AstraZeneca has become a key player in the pharmaceutical industry, with a rich history that includes a focus on sustainability and corporate responsibility. The company is dedicated to creating a positive impact in healthcare while maintaining ethical standards and transparency in its operations. Worldwide, AstraZeneca maintains a robust pipeline of more than 199 projects, demonstrating its ongoing commitment to innovation and improving global health outcomes. By collaborating with various partners, AstraZeneca continues to push the boundaries of science to deliver life-changing therapies.